ArticleCancer letters2025
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway.
Yizheng Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleCancer letters2025
Yizheng Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.